Skip to content
Home/Companies/Healthcare/HTL Biotechnology
HB

HTL Biotechnology

Healthcare·France·Active·5yr hold

HTL Biotechnology is a healthcare company, headquartered in France.

Entry
2021
Hold
5yr
Status
Active
Est. EV
–

Who owns HTL Biotechnology?

HTL Biotechnology is currently owned by Montagu Private Equity through Montagu VI (2020 vintage), since 2021. Across its history, HTL Biotechnology has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-04-21

Montagu Private Equity
Most recent investor
Montagu Private Equity
Montagu VI · 2020 · Buyout
2 ownership periods · full history below

Key facts

HQFrance
SectorHealthcare

Ownership history

2 ownership periods · co-invest detected

Active
Currently held by Montagu Private Equity since 2021.
Co-invest · 2 holders · 2018 · present
Bridgepoint
BridgepointExited 2022
2018 · 2022 · Europe V (BE V) · 2014 · Buyout
Secondary · to
MOIC
–
Montagu Private Equity
Montagu Private EquityActive
2021 · present · Montagu VI · 2020 · Buyout
MOIC
–

More from Montagu VI

Other portfolio companies in the same fund.

BMC Helix
Active
SoftwareUnited States· 2026
DQS
Active
Business ServicesGermany· 2026
Teleflex Medical OEM
Active
HealthcareUnited States· 2026
EXALTA
Active
HealthcareUnited States· 2025
IAI Group
Active
TMTPoland· 2025
Multifonds
Active
FinancialsLuxembourg· 2025

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
A Place for Mom
Active
Silver LakeUS
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abbisko Healthcare
Active
The Carlyle GroupChina
Abode Healthcare
Active
Summit PartnersUS
AccentCare
Active
Advent InternationalUS
Data refreshed weekly · Sourced from public filings